These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38230339)

  • 21. Current Practices in Operationalizing and Addressing Racial Equity in the Provision of Type 1 Diabetes Care: Insights from the Type 1 Diabetes Exchange Quality Improvement Collaborative Health Equity Advancement Lab.
    Addala A; Mungmode A; Ospelt E; Sanchez JE; Malik F; Demeterco-Berggren C; Butler A; Edwards C; Manukyan M; Ochoa-Maya M; Zupa M; Ebekozien O
    Endocr Pract; 2024 Jan; 30(1):41-48. PubMed ID: 37806550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inequity in access to continuous glucose monitoring and health outcomes in paediatric diabetes, a case for national continuous glucose monitoring funding: A cross-sectional population study of children with type 1 diabetes in New Zealand.
    Burnside MJ; Williman JA; Davies HM; Jefferies CA; Paul RG; Wheeler BJ; Wiltshire EJ; Anderson YC; de Bock MI
    Lancet Reg Health West Pac; 2023 Feb; 31():100644. PubMed ID: 36419466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disparities in Continuous Glucose Monitoring Use Among Women of Reproductive Age with Type 1 Diabetes in the T1D Exchange.
    Venkatesh KK; Powe CE; Buschur E; Wu J; Landon MB; Gabbe S; Gandhi K; Grobman WA; Fareed N
    Diabetes Technol Ther; 2023 Mar; 25(3):201-205. PubMed ID: 36753706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Observational Crossover Study of People Using Real-Time Continuous Glucose Monitors Versus Self-Monitoring of Blood Glucose: Real-World Evidence Using EMR Data From More Than 12,000 People With Type 1 Diabetes.
    Noor N; Norman G; Sonabend R; Chao L; Kamboj M; Golden L; Bekx MT; Hseih S; Levy C; Sanchez J; Rapaport R; Ebekozien O
    J Diabetes Sci Technol; 2023 Jun; ():19322968231178017. PubMed ID: 37264642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating Factors Associated With Continuous Glucose Monitoring Utilization With the Type 1 Diabetes Exchange Registry.
    Bailey R; Donthi S; Markt S; Drummond C; Cullen J
    J Diabetes Sci Technol; 2023 Nov; 17(6):1580-1589. PubMed ID: 35506181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Comparison of Continuous Glucose Monitoring Estimated Hemoglobin A1c in Adults with Type 1 or Type 2 Diabetes.
    Salam M; Bailey R; Calhoun P; McGill JB; Bergenstal RM; Price D; Beck RW
    Diabetes Technol Ther; 2023 Mar; 25(3):178-185. PubMed ID: 36472504
    [No Abstract]   [Full Text] [Related]  

  • 28. Diabetes Technology Use in Remote Pediatric Patients with Type 1 Diabetes Using Clinic-to-Clinic Telemedicine.
    Cobry EC; Reznick-Lipina T; Pyle L; Slover R; Thomas JF; Alonso GT; Wadwa RP
    Diabetes Technol Ther; 2022 Jan; 24(1):67-74. PubMed ID: 34524007
    [No Abstract]   [Full Text] [Related]  

  • 29. CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.
    Fonseca VA; Grunberger G; Anhalt H; Bailey TS; Blevins T; Garg SK; Handelsman Y; Hirsch IB; Orzeck EA; Roberts VL; Tamborlane W;
    Endocr Pract; 2016 Aug; 22(8):1008-21. PubMed ID: 27214060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing Social Determinants of Health Screening Rates Among Six Endocrinology Centers Across the United States: Results From the T1D Exchange Quality Improvement Collaborative.
    Odugbesan O; Wright T; Jones NY; Dei-Tutu S; Gallagher MP; DeWit E; Izquierdo RE; Desimone M; Rioles N; Ebekozien O;
    Clin Diabetes; 2024; 42(1):49-55. PubMed ID: 38230332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving pediatric endocrinology trainees' knowledge about insulin pumps and continuous glucose monitors with online spaced education: Technology Knowledge Optimization in T1D (TeKnO T1D).
    Marks BE; Waldman G; Reardon K; Terrio S; Kumar A; Stafford DEJ; Garvey KC; Wolfsdorf JI
    Pediatr Diabetes; 2020 Aug; 21(5):814-823. PubMed ID: 32222056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial disparities in treatment and outcomes of children with type 1 diabetes.
    Lipman TH; Smith JA; Patil O; Willi SM; Hawkes CP
    Pediatr Diabetes; 2021 Mar; 22(2):241-248. PubMed ID: 33871154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Change in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark Study.
    Gilbert TR; Noar A; Blalock O; Polonsky WH
    Diabetes Technol Ther; 2021 Mar; 23(S1):S35-S39. PubMed ID: 33470882
    [No Abstract]   [Full Text] [Related]  

  • 34. Social Risk Screening and Response Equity: Assessment by Race, Ethnicity, and Language in Community Health Centers.
    Torres CIH; Gold R; Kaufmann J; Marino M; Hoopes MJ; Totman MS; Aceves B; Gottlieb LM
    Am J Prev Med; 2023 Aug; 65(2):286-295. PubMed ID: 36990938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale and Design for a GRADE Substudy of Continuous Glucose Monitoring.
    Larkin ME; Nathan DM; Bebu I; Krause-Steinrauf H; Herman WH; Higgins JM; Tiktin M; Cohen RM; Lund C; Bergenstal RM; Johnson ML; Arends V;
    Diabetes Technol Ther; 2019 Dec; 21(12):682-690. PubMed ID: 31393176
    [No Abstract]   [Full Text] [Related]  

  • 36. Inequities in Diabetic Ketoacidosis Among Patients With Type 1 Diabetes and COVID-19: Data From 52 US Clinical Centers.
    Ebekozien O; Agarwal S; Noor N; Albanese-O'Neill A; Wong JC; Seeherunvong T; Sanchez J; DeSalvo D; Lyons SK; Majidi S; Wood JR; Acharya R; Aleppo G; Sumpter KM; Cymbaluk A; Shah NA; Van Name M; Cruz-Aviles L; Alonso GT; Gallagher MP; Sanda S; Feuer AJ; Cossen K; Rioles N; Jones NY; Kamboj MK; Hirsch IB
    J Clin Endocrinol Metab; 2021 Mar; 106(4):e1755-e1762. PubMed ID: 33410917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving Continuous Glucose Monitoring Uptake in Underserved Youth with Type 1 Diabetes: The IMPACT Study.
    Lin T; Manfredo JA; Illesca N; Abiola K; Hwang N; Salsberg S; Akhtar Y; Mathioudakis N; Brown EA; Wolf RM
    Diabetes Technol Ther; 2023 Jan; 25(1):13-19. PubMed ID: 36223197
    [No Abstract]   [Full Text] [Related]  

  • 38. Help when you need it: Perspectives of adults with T1D on the support and training they would have wanted when starting CGM.
    Tanenbaum ML; Messer LH; Wu CA; Basina M; Buckingham BA; Hessler D; Mulvaney SA; Maahs DM; Hood KK
    Diabetes Res Clin Pract; 2021 Oct; 180():109048. PubMed ID: 34534592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Satisfaction with continuous glucose monitoring is associated with quality of life in young people with type 1 diabetes regardless of metabolic control and treatment type.
    Franceschi R; Pertile R; Marigliano M; Mozzillo E; Maffeis C; Morotti E; Di Candia F; Fedi L; Iafusco D; Zanfardino A; Cauvin V; Maltoni G; Zucchini S; Cherubini V; Tiberi V; Minuto N; Bassi M; Rabbone I; Savastio S; Tinti D; Tornese G; Schiaffini R; Passanisi S; Lombardo F; Bonfanti R; Scaramuzza A; Troncone A
    Diabet Med; 2024 Jun; 41(6):e15307. PubMed ID: 38383984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applying the use of shared medical appointments (SMAs) to improve continuous glucose monitor (CGM) use, glycemic control, and quality of life in marginalized youth with type 1 diabetes: Study protocol for a pilot prospective cohort study.
    Grundman JB; Majidi S; Perkins A; Streisand R; Monaghan M; Marks BE
    Contemp Clin Trials Commun; 2023 Apr; 32():101067. PubMed ID: 36698741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.